PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDO L-5-YL)PYRAZOLE-4-CARBOXYLIC ACID
The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid, or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using same. The pharmaceutical composition acc...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
15.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid, or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using same. The pharmaceutical composition according to the present invention can effectively reduce the blood uric acid concentration of a patient with a hyperuricemia-related disease.
La presente invención se refiere a una composición farmacéutica que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-ca rboxílico o una sal farmacéuticamente aceptable de este, y un método para tratar o prevenir una enfermedad relacionada con la hiperuricemia usándolo, y la composición farmacéutica de la presente invención puede reducir de manera eficaz la concentración de ácido úrico en sangre en un paciente con una enfermedad relacionada con la hiperuricemia. |
---|---|
Bibliography: | Application Number: MX20230014359 |